Inflammatory bowel disease therapies discontinued between 2009 and 2014-Reference-Cited by-同舟云学术

Inflammatory bowel disease therapies discontinued between 2009 and 2014

Published:2015-04-10 Issue:7 Volume:24 Page:949-956
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Mozaffari Shilan¹,Nikfar Shekoufeh²,Abdollahi Mohammad¹

Affiliation:

1. 1Tehran University of Medical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Department of Toxicology and Pharmacology, Tehran, Iran

2. 2Tehran University of Medical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Department of Pharmacoeconomics and Pharmaceutical Administration, Tehran, Iran

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.2015.1035432

Reference43 articles.

1. Inflammatory Bowel Disease

2. A Meta-Analysis of the Efficacy of Sulfasalazine in Comparison with 5-Aminosalicylates in the Induction of Improvement and Maintenance of Remission in Patients with Ulcerative Colitis

3. Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis

4. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials

5. Efficacy and Tolerability of Immunoregulators and Antibiotics in Fistulizing Crohns Disease: A Systematic Review and Meta-analysis of Placebo-controlled Trials

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Initial Characterization of the First ¹⁸F-CXCR2-Targeting Radiotracer for PET Imaging of Neutrophils;Journal of Medicinal Chemistry;2024-04-04

2. AN INTEGRIN RENAISSANCE: RECENT PROGRESS OF INTEGRIN MODULATORS IN THE CLINIC;Medicinal Chemistry Reviews;2023-11-16

3. Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease;Gastroenterology;2022-05

4. Identification of novel chemotypes as CXCR2 antagonists via a scaffold hopping approach from a thiazolo[4,5-d]pyrimidine;European Journal of Medicinal Chemistry;2022-05

5. The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease;Frontiers in Physiology;2022-02-11